🇺🇸 FDA
Patent

US 12144815

Use of aprepitant for treating Alzheimer's disease

granted A61KA61K31/192A61K31/27

Quick answer

US patent 12144815 (Use of aprepitant for treating Alzheimer's disease) held by Hoth Therapeutics, Inc. expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Hoth Therapeutics, Inc.
Grant date
Tue Nov 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K31/192, A61K31/27, A61K31/407, A61K31/415